KORU Medical Systems Inc (KRMD) reports a 23% revenue increase and expands its international footprint, while addressing challenges in the immunoglobulin market.

Piper Sandler analyst Jason Bednar maintained a Hold rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of ...

Q4 2024 Earnings Call Transcript March 12, 2025 Operator: Greetings. And welcome to the KORU Medical Systems’ Fourth Quarter ...

Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of $6.00.

KORU Medical Systems (NASDAQ:KRMD – Get Free Report) is expected to issue its quarterly earnings data after the market closes on Wednesday, March 12th. Analysts expect the company to announce earnings ...

We came across a bullish thesis on KORU Medical Systems, Inc. (KRMD) on Substack by Shareholdersunite. In this article, we ...

MAHWAH, N.J., February 19, 2025--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing ...

Integer (ITGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ...

Another stock from the same industry, KORU Medical Systems Inc. (KRMD), closed the last trading session 0.9% higher at $3.22. Over the past month, KRMD has returned -30.7%. KORU Medical Systems ...